Back to search page

TRFR20170905001

Therapeutic innovations for diseases of the nervous system with high unmet medical needs

TECHNOLOGY PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A French pharmaceutical company is specialized in developing innovative treatments for diseases of the nervous system with high unmet medical needs. Within the frame of its development as fully integrated pharmaceutical company, it is currently looking for new assets for its portfolio in the field of neurological disorders. This company is considering license and/or research cooperation agreement as well as joint-venture agreement.


FULL DESCRIPTION

A French pharmaceutical company specialized in neurological diseases with high unmet medical needs. Its core focus lies on the metabolic alterations of central nervous system diseases as novel therapeutic approach.

The company's pipeline is currently composed of one molecule that has successfully finished phase III, two further compounds in late preclinical development and they have their own research platform to identify further promising therapeutic targets.

Within the frame of their development as fully integrated pharmaceutical company, it is now looking for new assets for the extension of its portfolio in the field of central nervous system disorders with high unmet medical needs. It is interested in new best- or first-in-class assets (new chemical entity, biologicals, repurposed drugs) preferentially targeting brain metabolism from early developmental stages (drug discovery) to late clinical phases. With its track record of successfully developed molecules and its expertise to progress the development of drugs from discovery to commercialisation, it is able to provide new treatment solutions for patients in need.

The French company is flexible concerning deal structure and is opened to different types of partnerships including in-licensing, co-development, research and development collaboration or sponsored research with both industrial and academic partners.


Partner expertise sought:

- Type of partner sought: Research institutes, hospital or biotechnological and pharmaceutical companies with therapeutic assets that are looking for a partner to develop the molecules through preclinical and clinical stages towards commercialisation.
- Specific area of activity of the partner: Industrial and academic partners, open for licensing, co-development, sponsored research with a pharmaceutical company

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
FRANCE
Profile date
18/09/2018
Deadline
31/03/2019

PARTNERSHIP(S) SOUGHT

License agreement Joint venture agreement Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Life Sciences \ Biosciences and Health \ Engineering \ Recycling & Waste Management \ Drug Discovery and Drug Development \ Diagnostics \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Medical Research / BIOLOGICAL SCIENCES / Medicine, Human Health / Neurology, Brain Research / BIOLOGICAL SCIENCES / Medicine, Human Health / Pharmaceutical Products / Drugs / BIOLOGICAL SCIENCES / Medicine, Human Health / Physiology
COMMERCIAL KEYWORDS
Other human health activities
MARKET KEYWORDS
MEDICAL/HEALTH RELATED / Therapeutic / Therapeutic services

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number TRFR20170905001